SEC Comment Letter 0000000000-24-004788 to BIODESIX INC (BDSX) (CIK 0001439725) (BDSX)
BIODESIX INC (BDSX) (CIK 0001439725)
Date: April 30, 2024 · CIK: 0001439725 · Accession: 0000000000-24-004788
AI Filing Summary & Sentiment
File numbers found in text: 333-278881
Letter
United States securities and exchange commission logo April 30, 2024 Scott Hutton Chief Executive Officer Biodesix, Inc. 919 West Dillon Rd. Louisville, Colorado 80027 Re:Biodesix, Inc. Registration Statement on Form S-1 Filed April 23, 2024 File No. 333-278881 Dear Scott Hutton: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Samir Gandhi, Esq.
Show Raw Text
United States securities and exchange commission logo
April 30, 2024
Scott Hutton
Chief Executive Officer
Biodesix, Inc.
919 West Dillon Rd.
Louisville, Colorado 80027
Re:Biodesix, Inc.
Registration Statement on Form S-1
Filed April 23, 2024
File No. 333-278881
Dear Scott Hutton:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Samir Gandhi, Esq.